The RECOVAC IR study: the immune response and safety of the mRNA-1273 COVID-19 vaccine in patients with chronic kidney disease, on dialysis or living with a kidney transplant

Marcia M.L. Kho; Marlies E.J. Reinders; RECOVAC Consortium / RECOVAC Collaborators; Carla C. Baan; Debbie van Baarle; Frederike J. Bemelman; Dimitri A. Diavatopoulos; Ron T. Gansevoort; Fiona R.M. van der Klis; Marion P.G. Koopmans; A. Lianne Messchendorp; Renate G. van der Molen; Ester B.M. Remmerswaal; Nynke Rots; Priya Vart; Rory D. de Vries; Luuk B. Hilbrands; Jan Stephan F. Sanders

doi:10.1093/ndt/gfab186

The RECOVAC IR study: the immune response and safety of the mRNA-1273 COVID-19 vaccine in patients with chronic kidney disease, on dialysis or living with a kidney transplant

Marcia M.L. Kho, Marlies E.J. Reinders, RECOVAC Consortium / RECOVAC Collaborators, Carla C. Baan, Debbie van Baarle, Frederike J. Bemelman, Dimitri A. Diavatopoulos, Ron T. Gansevoort, Fiona R.M. van der Klis, Marion P.G. Koopmans, A. Lianne Messchendorp, Renate G. van der Molen, Ester B.M. Remmerswaal, Nynke Rots, Priya Vart, Rory D. de Vries, Luuk B. Hilbrands, Jan Stephan F. Sanders

Research output: Contribution to journal › Article › Academic › peer-review

31 Citations (Scopus)

152 Downloads (Pure)

Original language	English
Pages (from-to)	1761-1764
Number of pages	4
Journal	Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Volume	36
Issue number	9
Early online date	26 May 2021
DOIs	https://doi.org/10.1093/ndt/gfab186
Publication status	Published - 26 May 2021

Bibliographical note

Funding Information:
This study is funded by the Netherlands Organization for
Health Research and Development (ZonMw), project number
10430072010002.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/ndt/gfab186Licence: CC BY-NC

The RECOVAC IR study, the immune response and safety of the mRNA-1273 COVID-19 vaccine in patients with chronic kidney disease, on dialysis or living with a kidney transplantFinal published version, 338 KBLicence: CC BY-NC
gfab186Licence: CC BY-NC

Cite this

Kho, M. M. L., Reinders, M. E. J., RECOVAC Consortium / RECOVAC Collaborators, Baan, C. C., van Baarle, D., Bemelman, F. J., Diavatopoulos, D. A., Gansevoort, R. T., van der Klis, F. R. M., Koopmans, M. P. G., Messchendorp, A. L., van der Molen, R. G., Remmerswaal, E. B. M., Rots, N., Vart, P., de Vries, R. D., Hilbrands, L. B., & Sanders, J. S. F. (2021). The RECOVAC IR study: the immune response and safety of the mRNA-1273 COVID-19 vaccine in patients with chronic kidney disease, on dialysis or living with a kidney transplant. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 36(9), 1761-1764. https://doi.org/10.1093/ndt/gfab186

Kho, Marcia M.L. ; Reinders, Marlies E.J. ; RECOVAC Consortium / RECOVAC Collaborators et al. / The RECOVAC IR study : the immune response and safety of the mRNA-1273 COVID-19 vaccine in patients with chronic kidney disease, on dialysis or living with a kidney transplant. In: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2021 ; Vol. 36, No. 9. pp. 1761-1764.

@article{dfb4927a5d454454a30433f8886edb18,

title = "The RECOVAC IR study: the immune response and safety of the mRNA-1273 COVID-19 vaccine in patients with chronic kidney disease, on dialysis or living with a kidney transplant",

author = "Kho, {Marcia M.L.} and Reinders, {Marlies E.J.} and {RECOVAC Consortium / RECOVAC Collaborators} and Baan, {Carla C.} and {van Baarle}, Debbie and Bemelman, {Frederike J.} and Diavatopoulos, {Dimitri A.} and Gansevoort, {Ron T.} and {van der Klis}, {Fiona R.M.} and Koopmans, {Marion P.G.} and Messchendorp, {A. Lianne} and {van der Molen}, {Renate G.} and Remmerswaal, {Ester B.M.} and Nynke Rots and Priya Vart and {de Vries}, {Rory D.} and Hilbrands, {Luuk B.} and Sanders, {Jan Stephan F.}",

note = "Funding Information: This study is funded by the Netherlands Organization for Health Research and Development (ZonMw), project number 10430072010002.",

year = "2021",

month = may,

day = "26",

doi = "10.1093/ndt/gfab186",

language = "English",

volume = "36",

pages = "1761--1764",

journal = "Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association",

issn = "0931-0509",

publisher = "Oxford University Press",

number = "9",

}

Kho, MML, Reinders, MEJ, RECOVAC Consortium / RECOVAC Collaborators, Baan, CC, van Baarle, D, Bemelman, FJ, Diavatopoulos, DA, Gansevoort, RT, van der Klis, FRM, Koopmans, MPG, Messchendorp, AL, van der Molen, RG, Remmerswaal, EBM, Rots, N, Vart, P, de Vries, RD, Hilbrands, LB & Sanders, JSF 2021, 'The RECOVAC IR study: the immune response and safety of the mRNA-1273 COVID-19 vaccine in patients with chronic kidney disease, on dialysis or living with a kidney transplant', Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, vol. 36, no. 9, pp. 1761-1764. https://doi.org/10.1093/ndt/gfab186

The RECOVAC IR study: the immune response and safety of the mRNA-1273 COVID-19 vaccine in patients with chronic kidney disease, on dialysis or living with a kidney transplant. / Kho, Marcia M.L.; Reinders, Marlies E.J.; RECOVAC Consortium / RECOVAC Collaborators et al.
In: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 36, No. 9, 26.05.2021, p. 1761-1764.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - The RECOVAC IR study

T2 - the immune response and safety of the mRNA-1273 COVID-19 vaccine in patients with chronic kidney disease, on dialysis or living with a kidney transplant

AU - Kho, Marcia M.L.

AU - Reinders, Marlies E.J.

AU - RECOVAC Consortium / RECOVAC Collaborators

AU - Baan, Carla C.

AU - van Baarle, Debbie

AU - Bemelman, Frederike J.

AU - Diavatopoulos, Dimitri A.

AU - Gansevoort, Ron T.

AU - van der Klis, Fiona R.M.

AU - Koopmans, Marion P.G.

AU - Messchendorp, A. Lianne

AU - van der Molen, Renate G.

AU - Remmerswaal, Ester B.M.

AU - Rots, Nynke

AU - Vart, Priya

AU - de Vries, Rory D.

AU - Hilbrands, Luuk B.

AU - Sanders, Jan Stephan F.

N1 - Funding Information: This study is funded by the Netherlands Organization for Health Research and Development (ZonMw), project number 10430072010002.

PY - 2021/5/26

Y1 - 2021/5/26

UR - http://www.scopus.com/inward/record.url?scp=85111943835&partnerID=8YFLogxK

U2 - 10.1093/ndt/gfab186

DO - 10.1093/ndt/gfab186

M3 - Article

C2 - 34450647

AN - SCOPUS:85111943835

SN - 0931-0509

VL - 36

SP - 1761

EP - 1764

JO - Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

JF - Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

IS - 9

ER -

Kho MML, Reinders MEJ, RECOVAC Consortium / RECOVAC Collaborators, Baan CC, van Baarle D, Bemelman FJ et al. The RECOVAC IR study: the immune response and safety of the mRNA-1273 COVID-19 vaccine in patients with chronic kidney disease, on dialysis or living with a kidney transplant. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2021 May 26;36(9):1761-1764. Epub 2021 May 26. doi: 10.1093/ndt/gfab186

The RECOVAC IR study: the immune response and safety of the mRNA-1273 COVID-19 vaccine in patients with chronic kidney disease, on dialysis or living with a kidney transplant

Bibliographical note

UN SDGs

Access to Document

Other files and links

Cite this